HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FRMD5
FERM domain containing 5
Chromosome 15 Β· 15q15.3
NCBI Gene: 84978Ensembl: ENSG00000171877.21HGNC: HGNC:28214UniProt: A0A087WVP2
28PubMed Papers
21Diseases
0Drugs
6Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
integrin bindingprotein bindingprotein kinase bindingregulation of cell migrationneurodevelopmental disorder with eye movement abnormalities and ataxianeurodegenerative diseaseCOVID-19metabolic syndrome
✦AI Summary

FRMD5 (FERM domain containing 5) is a scaffolding protein that plays critical roles in neurodevelopment and cell motility regulation. The protein localizes at cell adherens junctions where it stabilizes cell-cell contacts and regulates cell-matrix interactions through binding to integrin Ξ²5 subunit 1. FRMD5 inhibits cell migration by promoting cell-matrix adhesion and cell spreading on vitronectin, while also interacting with ROCK1 kinase to inhibit myosin light chain phosphorylation and actin stress fiber formation 1. In neurodevelopment, FRMD5 is essential for proper neuronal morphology and synaptic function, with deficiency leading to learning and memory dysfunction, impaired social function, and repetitive behaviors in mouse models 2. The protein is also a direct transcriptional target of the Ξ²-catenin/TCF7L2 complex, linking it to Wnt signaling pathways 3. Clinically, de novo heterozygous missense variants in FRMD5 cause a neurodevelopmental disorder characterized by developmental delay, intellectual disability, childhood-onset ataxia, abnormal eye movements including nystagmus, and seizures 45. Functional studies demonstrate that pathogenic variants behave as partial loss-of-function or dominant-negative alleles, supporting FRMD5's intolerance to functional disruption 4. These findings establish FRMD5 as an important regulator of both cellular adhesion and neurological development.

Sources cited
1
FRMD5 regulates cell migration through binding to integrin Ξ²5 subunit and ROCK1, affecting cell-matrix adhesion and actin stress fiber formation
PMID: 25448675
2
FRMD5 deficiency results in neurodevelopmental dysfunction, learning and memory deficits, and autism-like behaviors in mice
PMID: 38228891
3
De novo FRMD5 variants cause developmental delay, intellectual disability, ataxia, and eye movement abnormalities in humans
PMID: 36206744
4
FRMD5 variants are associated with childhood-onset ataxia, nystagmus, and seizures
PMID: 38576116
5
FRMD5 is a direct transcriptional target of the Ξ²-catenin/TCF7L2 complex
PMID: 28117551
Disease Associationsβ“˜21
neurodevelopmental disorder with eye movement abnormalities and ataxiaOpen Targets
0.75Strong
neurodegenerative diseaseOpen Targets
0.33Weak
COVID-19Open Targets
0.33Weak
metabolic syndromeOpen Targets
0.32Weak
benign neoplasm of eyeOpen Targets
0.31Weak
Alzheimer diseaseOpen Targets
0.31Weak
schizophreniaOpen Targets
0.22Weak
genetic disorderOpen Targets
0.19Weak
developmental disorder of mental healthOpen Targets
0.18Weak
Neurodevelopmental delayOpen Targets
0.12Weak
papillary thyroid carcinomaOpen Targets
0.07Suggestive
Female infertility due to fertilization defectOpen Targets
0.06Suggestive
attention deficit hyperactivity disorderOpen Targets
0.05Suggestive
early-onset non-syndromic cataractOpen Targets
0.05Suggestive
Cataract-microcornea syndromeOpen Targets
0.05Suggestive
female infertility due to oocyte meiotic arrestOpen Targets
0.05Suggestive
oocyte maturation defect 14Open Targets
0.05Suggestive
oocyte maturation defect 5Open Targets
0.05Suggestive
Cataract with Y-shaped suture opacitiesOpen Targets
0.04Suggestive
hereditary attention deficit-hyperactivity disorderOpen Targets
0.04Suggestive
Neurodevelopmental disorder with eye movement abnormalities and ataxiaUniProt
Pathogenic Variants6
NM_032892.5(FRMD5):c.1135+1G>APathogenic
not provided
β˜…β˜†β˜†β˜†2025
NM_032892.5(FRMD5):c.947G>T (p.Arg316Leu)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 316
NM_032892.5(FRMD5):c.1124C>T (p.Ser375Phe)Likely pathogenic
Neurodevelopmental disorder with eye movement abnormalities and ataxia
β˜…β˜†β˜†β˜†2024β†’ Residue 375
NM_032892.5(FRMD5):c.1052G>A (p.Ser351Asn)Likely pathogenic
Neurodevelopmental disorder with eye movement abnormalities and ataxia
β˜…β˜†β˜†β˜†2023β†’ Residue 351
NM_032892.5(FRMD5):c.1051A>G (p.Ser351Gly)Pathogenic
Neurodevelopmental disorder with eye movement abnormalities and ataxia
β˜†β˜†β˜†β˜†2022β†’ Residue 351
NM_032892.5(FRMD5):c.1060T>C (p.Ser354Pro)Pathogenic
Neurodevelopmental disorder with eye movement abnormalities and ataxia
β˜†β˜†β˜†β˜†2022β†’ Residue 354
View on ClinVar β†—
Related Genes
EPB41L4BShared pathway25%FRMD3Shared pathway25%EPB41L4AShared pathway25%ALKBH4Shared pathway25%EPB41L1Shared pathway20%SPOCK3Shared pathway20%
Tissue Expression6 tissues
Heart
100%
Brain
32%
Bone Marrow
18%
Ovary
1%
Lung
0%
Liver
0%
Gene Interaction Network
Click a node to explore
FRMD5EPB41L4BFRMD3EPB41L4AALKBH4EPB41L1SPOCK3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q7Z6J6
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.49Moderately Constrained
pLIβ“˜
0.99Intolerant
Observed/Expected LoF0.32 [0.22–0.49]
RankingsWhere FRMD5 stands among ~20K protein-coding genes
  • #12,351of 20,598
    Most Researched28
  • #3,429of 5,498
    Most Pathogenic Variants6
  • #2,873of 17,882
    Most Constrained (LOEUF)0.49 Β· top quartile
Genes detectedFRMD5
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice.
PMID: 38228891
Mol Psychiatry Β· 2024
1.00
2
Integrative variants, haplotypes and diplotypes of the CAPN3 and FRMD5 genes and several environmental exposures associate with serum lipid variables.
PMID: 28332615
Sci Rep Β· 2017
0.90
3
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
PMID: 36206744
Am J Hum Genet Β· 2022
0.80
4
Identification of FERM domain-containing protein 5 as a novel target of Ξ²-catenin/TCF7L2 complex.
PMID: 28117551
Cancer Sci Β· 2017
0.70
5
C-terminal truncated HBx protein activates caveolin-1/LRP6/Ξ²-catenin/FRMD5 axis in promoting hepatocarcinogenesis.
PMID: 30583072
Cancer Lett Β· 2019
0.60